Key Events This Week
May 11: New 52-week high at Rs.8,129.90
May 11: Technical momentum shifts signal bullish outlook
May 12: Upgraded to Buy on strong fundamentals and technicals
May 14: New 52-week high of Rs.8,150
May 15: New 52-week high at Rs.8,249.95
May 11: New 52-Week High and Technical Momentum Shift
On 11 May 2026, Apollo Hospitals reached a new 52-week high of Rs.8,129.90, marking a significant milestone amid a broader market downturn. The stock closed at Rs.8,080.95, down marginally by 0.17% from the previous close but still demonstrating strength relative to the Sensex, which fell 1.40% that day. This price level placed Apollo comfortably above all key moving averages, signalling a bullish technical setup.
Technical indicators showed a positive shift, with the Moving Average Convergence Divergence (MACD) turning bullish on weekly charts and Bollinger Bands expanding on the upside. The stock’s daily moving averages also turned bullish, reinforcing the momentum. Despite a mildly bearish monthly MACD, the short-term outlook was optimistic, supported by a neutral Relative Strength Index (RSI) and balanced On-Balance Volume (OBV).
This technical momentum shift was accompanied by Apollo Hospitals outperforming the Sensex and its hospital sector peers, highlighting its resilience in a volatile environment.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
May 12: Upgrade to Buy Rating on Strong Fundamentals and Technicals
MarketsMOJO upgraded Apollo Hospitals from a Hold to a Buy rating on 12 May 2026, reflecting improvements in quality, valuation, financial trends, and technical indicators. The company’s Return on Capital Employed (ROCE) stood at a robust 16.84%, with net sales for the latest quarter reaching a record Rs.6,477.40 crores and PBDIT hitting Rs.965.30 crores.
The upgrade was supported by Apollo’s attractive valuation metrics, including an Enterprise Value to Capital Employed ratio of 8.7 and a PEG ratio of 1.7, indicating reasonable pricing relative to earnings growth. The company’s market capitalisation of Rs.1,16,250 crores made it the largest hospital sector entity, commanding 19.27% of the sector’s market cap.
Financial trends remained strong, with annual net sales growth of 17.93% and operating profit margins of 39.35%. The stock’s technical momentum also strengthened, with bullish daily moving averages and weekly MACD, despite some caution from monthly indicators.
On 12 May, the stock traded near its 52-week high of Rs.8,143.25, closing at Rs.8,019.60, down 0.76% on the day but maintaining its position near the upper trading band.
May 13: Consolidation Amid Mixed Market Signals
On 13 May, Apollo Hospitals saw a slight decline of 0.23% to close at Rs.8,001.20, with very low volume of 10,288 shares traded. The Sensex, however, gained 0.32%, closing at 35,010.26. This day’s price action reflected a consolidation phase following the recent gains and rating upgrade, with the stock maintaining its position above key moving averages.
Technical indicators remained cautiously optimistic, with no significant changes in momentum. The low volume suggested a wait-and-watch approach by investors amid broader market volatility.
May 14: New 52-Week High of Rs.8,150 Amid Market Volatility
Apollo Hospitals rebounded strongly on 14 May, hitting a new 52-week high of Rs.8,150 and closing at Rs.8,115.80, up 1.43% on the day. This performance outpaced its hospital sector peers by 0.98%, signalling renewed buying interest. The stock traded comfortably above all major moving averages, reinforcing its bullish technical stance.
In contrast, the Sensex closed down 0.36%, reflecting broader market caution. Apollo’s ability to buck the trend highlighted its relative strength and investor confidence in its fundamentals and growth prospects.
Financially, the company’s strong ROCE of 16.84%, low Debt to EBITDA ratio of 2.40 times, and consistent quarterly growth underpinned the rally. The stock’s valuation remained attractive, trading at a discount relative to peers’ historical averages.
Get the full story on Apollo Hospitals Enterprise Ltd.! Our detailed research dives into fundamentals, sector comparison, technical analysis, and valuations for this large-cap. Make informed decisions!
- - Full research story
- - Sector comparison done
- - Informed decision support
May 15: New 52-Week High at Rs.8,249.95 Caps the Week
On the final trading day of the week, Apollo Hospitals reached its highest 52-week and all-time high of Rs.8,249.95. Despite a marginal day change of -0.42%, the stock closed at Rs.8,081.60, maintaining its position above key moving averages and signalling sustained bullish momentum.
The broader market was mixed, with the Sensex down 0.36% at 35,236.50. Apollo’s outperformance over the week and year-to-date remains notable, with a 1-year return of 14.76% compared to the Sensex’s decline of 8.37%.
Institutional investors hold a significant 65.61% stake, reflecting strong confidence in the company’s fundamentals. Apollo’s dominant market position, commanding over 19% of the hospital sector’s market capitalisation and nearly 28% of sector sales, further supports its leadership status.
Daily Price Comparison: Apollo Hospitals vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-05-11 | Rs.8,080.95 | -0.17% | 35,679.54 | -1.40% |
| 2026-05-12 | Rs.8,019.60 | -0.76% | 34,899.09 | -2.19% |
| 2026-05-13 | Rs.8,001.20 | -0.23% | 35,010.26 | +0.32% |
| 2026-05-14 | Rs.8,115.80 | +1.43% | 35,364.44 | +1.01% |
| 2026-05-15 | Rs.8,081.60 | -0.42% | 35,236.50 | -0.36% |
Key Takeaways
Positive Signals: Apollo Hospitals demonstrated resilience by hitting multiple 52-week highs despite a broadly declining Sensex. The upgrade to a Buy rating by MarketsMOJO was supported by strong fundamentals including a high ROCE of 16.84%, consistent quarterly growth, and attractive valuation metrics. Technical indicators such as bullish daily moving averages, weekly MACD, and Bollinger Bands confirmed a positive momentum shift.
Cautionary Notes: Some monthly technical indicators like the MACD and KST remain mildly bearish, suggesting that longer-term trend confirmation is still developing. The stock’s volume was relatively low on certain days, indicating a cautious market participation. Investors should monitor these indicators for sustained confirmation of the uptrend.
Conclusion
The week ending 15 May 2026 saw Apollo Hospitals Enterprise Ltd. maintain its leadership within the hospital sector by delivering a near-flat weekly performance of -0.16%, significantly outperforming the Sensex’s 2.63% decline. The stock’s ability to set new 52-week highs on three separate occasions during the week, combined with a technical momentum shift and a rating upgrade, underscores its robust fundamentals and market positioning.
Strong financial metrics, including high ROCE, consistent sales growth, and prudent leverage, underpin the stock’s valuation and investor confidence. Institutional backing remains strong, with a 65.61% holding, reinforcing the company’s status as a large-cap bellwether in healthcare.
While some longer-term technical indicators advise caution, the overall outlook remains constructive. Apollo Hospitals’ performance amid a volatile market environment highlights its resilience and potential to sustain momentum in the near term.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
